658712-81-3 Usage
Uses
Used in Pharmaceutical Industry:
5,6,7,8-Tetrahydro-1,8-naphthyridin-2-propionic acid is used as a key building block for the synthesis of various bioactive compounds due to its unique structure and properties. It plays a crucial role in the development of new pharmaceuticals, potentially contributing to the creation of novel therapeutic agents.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 5,6,7,8-tetrahydro-1,8-naphthyridin-2-propionic acid is utilized as a valuable component in the design and synthesis of new drug candidates. Its heterocyclic nature and functional groups make it a versatile molecule for exploring various chemical modifications and interactions with biological targets.
Used in Drug Development:
5,6,7,8-Tetrahydro-1,8-naphthyridin-2-propionic acid is employed in drug development processes to create innovative pharmaceuticals with improved efficacy and selectivity. Its potential applications in this area are vast, and ongoing research aims to uncover its full potential in treating various diseases and conditions.
While the provided materials do not specify particular applications in different industries beyond the pharmaceutical sector, the compound's potential for industrial applications is acknowledged. Further research is necessary to fully explore its uses and properties in other fields.
Check Digit Verification of cas no
The CAS Registry Mumber 658712-81-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,8,7,1 and 2 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 658712-81:
(8*6)+(7*5)+(6*8)+(5*7)+(4*1)+(3*2)+(2*8)+(1*1)=193
193 % 10 = 3
So 658712-81-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H14N2O2/c14-10(15)6-5-9-4-3-8-2-1-7-12-11(8)13-9/h3-4H,1-2,5-7H2,(H,12,13)(H,14,15)
658712-81-3Relevant academic research and scientific papers
PIPERIDINYL COMPOUNDS THAT SELECTIVELY BIND INTEGRINS
-
Page 98, (2010/11/30)
The invention is directed to piperidinyl compounds of formula (I) and (II) that selectively bind integrin receptors and methods for treating an integrin mediated disorder, wherein W, R2, Z and q are described in the application.
